Takeda Pharmaceutical Company Limited revenue breakdown overview

Takeda Pharmaceutical Company Limited revenue for the last year amounted to 29.77 B USD, the most of which — 8.08 B USD — came from its highest performing source at the moment, Gastrointestinal, the year earlier bringing 7.79 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Takeda Pharmaceutical Company Limited 15.52 B USD, and the year before that — 15.26 B USD.